Authors: Seyger, MMB van den Hoogen, FHJ van Vlijmen-Willems, IMJJ van de Kerkhof, PCM de Jong, EMGJ

Citation: Mmb. Seyger et al., Localized and systemic scleroderma show different histological responses to methotrexate therapy, J PATHOLOGY, 193(4), 2001, pp. 511-516

Authors: Zeeuwen, PLJM van Vlijmen-Willems, IMJJ Jansen, BJH Sotiropoulou, G Curfs, JH Meis, JFGM Janssen, JJM van Ruissen, F Schalkwijk, J

Citation: Pljm. Zeeuwen et al., Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase, J INVES DER, 116(5), 2001, pp. 693-701

Authors: Seegers, BAMPA Andriessen, MPM van Hooijdonk, CAEM de Bakker, ESM van Vlijmen-Willems, IMJJ Parker, GL van Erp, PEJ van de Kerkhof, PCM

Citation: Bampa. Seegers et al., Pharmacological effects of a specific leukotriene B-4 receptor antagonist (VML 295) on blood leukocytes, cutaneous inflammation and epidermal proliferation, SKIN PH APP, 13(2), 2000, pp. 75-85

Authors: van der Vleuten, CJM van Vlijmen-Willems, IMJJ de Jong, EMGJ van de Kerkhof, PCM

Citation: Cjm. Van Der Vleuten et al., Clobetasol-17-propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse, ARCH DERM R, 291(7-8), 1999, pp. 390-395

Authors: Castelijns, FACM Gerritsen, MJP van Vlijmen-Willems, IMJJ van Erp, PEJ van de Kerkhof, PCM

Citation: Facm. Castelijns et al., The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis, J AM ACAD D, 40(6), 1999, pp. 901-909

Authors: Wingens, M van Bergen, BH Hiemstra, PS Meis, JFGM van Vlijmen-Willems, IMJJ Zeeuwen, PLJM Mulder, J Kramps, HA van Ruissen, F Schalkwijk, J

Citation: M. Wingens et al., Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes, J INVES DER, 111(6), 1998, pp. 996-1002